Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer

Last updated: April 24, 2025
Sponsor: Medical College of Wisconsin
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Metastatic Cancer

Treatment

Lifestyle Intervention

Attention Control

Clinical Study ID

NCT03824145
27600
  • Ages > 18
  • Female

Study Summary

This multi-site study is being conducted to examine dietary and activity patterns, body composition, blood and quality of life in breast cancer patients. The study will recruit 176 women with MBC in Milwaukee (n=88) and Chicago (n=88).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult (≥ 18 years), female

  • Confirmed Metastatic Breast Cancer

  • Patients clinically stable with treated brain metastases are eligible

  • Written documentation from their oncologist permitting study participation

  • Determined to be "clinically stable" by their medical oncologist (i.e., nounintentional weight loss, no new symptoms or change in performance status for thepast 4 weeks, no clinical [including laboratory] or radiologic evidence of diseaseprogression, no recent or planned change in anti-neoplastic therapies, no reports ofsevere pain [≥ Grade 3 per the NCI CTCAE)

  • Life expectancy >6 months

-Written documentation from their oncologist permitting study participation

  • Access to a mobile phone

  • Understand/speak English fluently.

  • Non-adherence to ACS nutritional or PA guidelines for cancer survivors as documentedby questionnaire.

Exclusion

Exclusion Criteria:

  • Does not meet the above criteria.

Study Design

Total Participants: 176
Treatment Group(s): 2
Primary Treatment: Lifestyle Intervention
Phase:
Study Start date:
November 01, 2022
Estimated Completion Date:
February 01, 2027

Study Description

Aims/Objectives

Aim 1. To examine the efficacy of the Every Day Counts intervention in producing significant post-intervention changes in multidimensional QOL in women with MBC.

Hypothesis 1: Women randomized to the immediate EDC intervention (n=88) will exhibit greater improvements in multidimensional QOL compared to women randomized to the attention control (n=88).

Aim 2. To investigate the mechanistic effects of the Every Day Counts intervention on body composition, adipokines, serum biomarkers of inflammation and insulin sensitivity.

Hypothesis 2: The EDC intervention leads to improved QOL through mediating factors including body composition, prognostic serum biomarkers of inflammation and/or insulin resistance.

Exploratory Aim 3: To explore if microRNA (miRNA) signatures associated with inflammation and/or Metabolomics are altered with the EDC intervention.

Hypothesis: miRNAs identified in our pilot study (miR-10a-5p, miR-205-5p, and miR-211-5p) that regulate inflammation and/or Metabolomics will be related to QOL improvements and can identify women more likely to respond to lifestyle changes.

Connect with a study center

  • Loyola University

    Maywood, Illinois 60153
    United States

    Active - Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin 53226
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.